VYNE Therapeutics (VYNE) - 2024 Q1 - Quarterly Results

Exhibit 99.1 VYNE Reports First Quarter 2024 Financial Results and Provides Business Update BRIDGEWATER, N.J., May 9, 2024 -- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company"), a clinical-stage biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno- inflammatory conditions, today announced financial results as of and for the three months ended March 31, 2024 and provided a business update. "During the first quarter, we m ...